Search research articles
Contact Us
Filters
Showing results (51-60 of 69) with videos related to
Page
of 7
Sort By:
Elife
|
January 8, 2016
Control of TSC2-Rheb signaling axis by arginine regulates mTORC1 activity
Bernadette Carroll, Dorothea Maetzel, Oliver Dk Maddocks, et al.
Elife
|
February 12, 2026
Correction: Control of TSC2-Rheb signaling axis by arginine regulates mTORC1 activity
Bernadette Carroll, Dorothea Maetzel, Oliver D K Maddocks, et al.
Oncogene
|
January 10, 2019
Correction: Loss of tuberous sclerosis complex 2 sensitizes tumors to nelfinavir-bortezomib therapy to intensify endoplasmic reticulum stress-induced cell death
Charlotte E Johnson, Elaine A Dunlop, Sara Seifan, et al.
Oncogene
|
July 8, 2018
Loss of tuberous sclerosis complex 2 sensitizes tumors to nelfinavir-bortezomib therapy to intensify endoplasmic reticulum stress-induced cell death
Charlotte E Johnson, Elaine A Dunlop, Sara Seifan, et al.
Autophagy
|
August 16, 2014
FLCN, a novel autophagy component, interacts with GABARAP and is regulated by ULK1 phosphorylation
Elaine A Dunlop, Sara Seifan, Tijs Claessens, et al.
Oncogene
|
March 26, 2025
Characterizing the tumor suppressor activity of FLCN in Birt-Hogg-Dubé syndrome cell models through transcriptomic and proteomic analysis
Rachel-Ann Jones, Elaine A Dunlop, Jesse D Champion, et al.
International Journal of Molecular Sciences
|
December 3, 2020
Distinctive Features of Orbital Adipose Tissue (OAT) in Graves' Orbitopathy
Lei Zhang, Anna Evans, Chris von Ruhland, et al.
European Journal of Human Genetics : EJHG
|
March 17, 2011
Determining the pathogenicity of patient-derived TSC2 mutations by functional characterization and clinical evidence
Elaine A Dunlop, Kayleigh M Dodd, Stephen C Land, et al.
The Journal of Biological Chemistry
|
April 5, 2012
Structure-activity analysis of niclosamide reveals potential role for cytoplasmic pH in control of mammalian target of rapamycin complex 1 (mTORC1) signaling
Bruno D Fonseca, Graham H Diering, Michael A Bidinosti, et al.
Cancers
|
December 23, 2022
Drug Inhibition of Redox Factor-1 Restores Hypoxia-Driven Changes in Tuberous Sclerosis Complex 2 Deficient Cells
Jesse D Champion, Kayleigh M Dodd, Hilaire C Lam, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 69) with videos related to
Sort By:
Page
of 7
Elife
|
January 8, 2016
Control of TSC2-Rheb signaling axis by arginine regulates mTORC1 activity
Bernadette Carroll, Dorothea Maetzel, Oliver Dk Maddocks, et al.
Elife
|
February 12, 2026
Correction: Control of TSC2-Rheb signaling axis by arginine regulates mTORC1 activity
Bernadette Carroll, Dorothea Maetzel, Oliver D K Maddocks, et al.
Oncogene
|
January 10, 2019
Correction: Loss of tuberous sclerosis complex 2 sensitizes tumors to nelfinavir-bortezomib therapy to intensify endoplasmic reticulum stress-induced cell death
Charlotte E Johnson, Elaine A Dunlop, Sara Seifan, et al.
Oncogene
|
July 8, 2018
Loss of tuberous sclerosis complex 2 sensitizes tumors to nelfinavir-bortezomib therapy to intensify endoplasmic reticulum stress-induced cell death
Charlotte E Johnson, Elaine A Dunlop, Sara Seifan, et al.
Autophagy
|
August 16, 2014
FLCN, a novel autophagy component, interacts with GABARAP and is regulated by ULK1 phosphorylation
Elaine A Dunlop, Sara Seifan, Tijs Claessens, et al.
Oncogene
|
March 26, 2025
Characterizing the tumor suppressor activity of FLCN in Birt-Hogg-Dubé syndrome cell models through transcriptomic and proteomic analysis
Rachel-Ann Jones, Elaine A Dunlop, Jesse D Champion, et al.
International Journal of Molecular Sciences
|
December 3, 2020
Distinctive Features of Orbital Adipose Tissue (OAT) in Graves' Orbitopathy
Lei Zhang, Anna Evans, Chris von Ruhland, et al.
European Journal of Human Genetics : EJHG
|
March 17, 2011
Determining the pathogenicity of patient-derived TSC2 mutations by functional characterization and clinical evidence
Elaine A Dunlop, Kayleigh M Dodd, Stephen C Land, et al.
The Journal of Biological Chemistry
|
April 5, 2012
Structure-activity analysis of niclosamide reveals potential role for cytoplasmic pH in control of mammalian target of rapamycin complex 1 (mTORC1) signaling
Bruno D Fonseca, Graham H Diering, Michael A Bidinosti, et al.
Cancers
|
December 23, 2022
Drug Inhibition of Redox Factor-1 Restores Hypoxia-Driven Changes in Tuberous Sclerosis Complex 2 Deficient Cells
Jesse D Champion, Kayleigh M Dodd, Hilaire C Lam, et al.
Page
of 7